Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| B-cell lymphocytosis and reprogramming due to biallelic CARD11 mutations. | J Allergy Clin Immunol | 2026 | 41456721 | PubTator, text mining | PubMed |
| Immunogenomic profiles of HIV-associated classic Hodgkin lymphoma from Malawi. | Blood Glob Hematol | 2025 | 42306579 | PubTator, text mining | PubMed |
| Geometry-Based Bounds on the Capacity of Peak-Limited and Band-Limited Signals over the Additive White Gaussian Noise Channel at a High SNR. | Entropy (Basel) | 2025 | 41440395 | PubTator, text mining | PubMed |
| Dupilumab for atopic manifestations in pediatric patients with inborn errors of immunity: efficacy and safety in a genetically diverse cohort. | Front Immunol | 2025 | 41357247 | PubTator, text mining | PubMed |
| Gene Expression Profiling Provides an Improved Characterization of CD79B-Mutated Diffuse Large B-Cell Lymphomas. | J Pers Med | 2025 | 41295250 | PubTator, text mining | PubMed |
| Evaluation of lymphoid defects in specific inborn errors of immunity using a single-tube multicolor flow cytometry assay. | Immunogenetics | 2025 | 41238939 | PubTator, text mining | PubMed |
| LUBAC modulates CBM complex functions downstream of TRAF6 in T cells. | Nat Commun | 2025 | 41213928 | PubTator, text mining | PubMed |
| Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement. | Genome Med | 2025 | 41137062 | PubTator, text mining | PubMed |
| METTL3 knockdown promotes the osteogenic differentiation of hPDLSCs by regulating CARD11 levels. | Clinics (Sao Paulo) | 2025 | 41092561 | PubTator, text mining | PubMed |
| Identifying the causal role and therapeutic potential of immune-related genes in bladder cancer: a Mendelian randomization study. | Discov Oncol | 2025 | 41082153 | PubTator, text mining | PubMed |
| Accelerated In Silico Discovery of SGR-1505: A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell Malignancies. | J Med Chem | 2025 | 41078320 | PubTator, text mining | PubMed |
| Comparative Analysis Reveals Recurrent Molecular Alterations in Low-Risk Human Papillomavirus 6 and Human Papillomavirus 11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva. | Mod Pathol | 2025 | 41077352 | PubTator, text mining | PubMed |
| Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets. | Br J Pharmacol | 2025 | 41057034 | PubTator, text mining | PubMed |
| Lenalidomide-rituximab with high-dose methotrexate for treatment of patients with newly diagnosed primary cns lymphoma: a promising first-line approach. | Ann Hematol | 2025 | 41037103 | PubTator, text mining | PubMed |
| Immunotherapy of Oncovirus-Induced Cancers: A Review on the Development and Efficacy of Targeted Vaccines. | Vaccines (Basel) | 2025 | 41012117 | PubTator, text mining | PubMed |
| Malignancy in Adults with Inborn Errors of Immunity: A Retrospective Single-Center Study. | J Clin Immunol | 2025 | 40993321 | PubTator, text mining | PubMed |
| Prediction of HER2-Low Breast Cancer via Multimodal Ultrasound Imaging. | Cancer Med | 2025 | 40891579 | PubTator, text mining | PubMed |
| Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era. | Blood Cancer J | 2025 | 40883287 | PubTator, text mining | PubMed |
| Exploration of Dendrobium officinale polysaccharide (DOP)'s potential targeted therapy in T-ALL combining network pharmacology, bioinformatics and experimental validation. | Int J Biol Macromol | 2025 | 40876683 | PubTator, text mining | PubMed |
| A mutational process signature and genomic alterations associated with outcome and immunogenicity in cancers with brain metastasis. | Front Immunol | 2025 | 40808963 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=3